The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 17, 2019
Filed:
Apr. 01, 2015
Applicant:
Merz Pharma Gmbh & Co. Kgaa, Frankfurt am Main, DE;
Inventors:
Lubin Belkovi, Friedrichsdorf, DE;
Franck Villain, Paris, FR;
Andreas Krause, Frankfurt am Main, DE;
Colin Drabe, Mainz, DE;
Assignee:
MERZ PHARMA GMBH & CO. KGAA, Frankfurt am Main, DE;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/375 (2006.01); A61K 8/22 (2006.01); A61K 31/729 (2006.01); A61K 33/40 (2006.01); A61Q 90/00 (2009.01); A61K 31/738 (2006.01); A61K 8/42 (2006.01); A61K 8/67 (2006.01); A61Q 19/08 (2006.01); A61K 45/06 (2006.01); A61K 31/07 (2006.01); A61K 31/167 (2006.01); A61K 31/355 (2006.01); A61K 33/20 (2006.01); A61K 33/24 (2019.01); A61K 33/26 (2006.01); A61K 33/34 (2006.01); A61K 31/122 (2006.01); A61K 33/18 (2006.01); A61K 33/30 (2006.01);
U.S. Cl.
CPC ...
A61K 8/22 (2013.01); A61K 8/42 (2013.01); A61K 8/676 (2013.01); A61K 31/07 (2013.01); A61K 31/122 (2013.01); A61K 31/167 (2013.01); A61K 31/355 (2013.01); A61K 31/375 (2013.01); A61K 31/738 (2013.01); A61K 33/18 (2013.01); A61K 33/20 (2013.01); A61K 33/24 (2013.01); A61K 33/26 (2013.01); A61K 33/30 (2013.01); A61K 33/34 (2013.01); A61K 33/40 (2013.01); A61K 45/06 (2013.01); A61Q 19/08 (2013.01); A61Q 90/00 (2013.01); A61K 2800/91 (2013.01);
Abstract
The present invention relates to a composition for the in vivo degradation of polysaccharide-containing fillers by radical degradation. The composition of the invention comprising at least one source of oxygen free radicals and at least one catalyst of oxygen free radical generation from the at least one source of oxygen free radicals. The present invention further relates to methods and uses of said composition for filler correction or reversal.